Common Contracts

195 similar Placement Agent Common Stock Purchase Warrant contracts by Citius Pharmaceuticals, Inc., GRI Bio, Inc., Kartoon Studios, Inc., others

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT soluna holdings, Inc.
Placement Agent Common Stock Purchase Warrant • June 16th, 2025 • Soluna Holdings, Inc • Finance services • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [the Stockholder Approval Date]1 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______2 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Soluna Holdings, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of April 29, 2025.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT processa pharmaceuticals, inc.
Placement Agent Common Stock Purchase Warrant • June 13th, 2025 • Processa Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [Stockholder Approval Date]1 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Processa Pharmaceuticals, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of May 27, 2025.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Citius Pharmaceuticals, Inc.
Placement Agent Common Stock Purchase Warrant • June 12th, 2025 • Citius Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 11, 2027 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Citius Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of April 10, 2024, as amended.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT HELIUS MEDICAL TECHNOLOGIES, INC.
Placement Agent Common Stock Purchase Warrant • May 23rd, 2025 • Helius Medical Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____, 20271 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Helius Medical Technologies, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to the Placement Agency Agreement (as defined below).

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Silo Pharma, Inc.
Placement Agent Common Stock Purchase Warrant • May 16th, 2025 • Silo Pharma, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 15, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Silo Pharma, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, dated as of March 5, 2025, by and between the Company and H.C. Wainwright & Co., LLC, as amended.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT GENPREX, INC.
Placement Agent Common Stock Purchase Warrant • May 14th, 2025 • Genprex, Inc. • Pharmaceutical preparations

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May ___, 20301 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Genprex, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Pasithea Therapeutics Corp.
Placement Agent Common Stock Purchase Warrant • May 7th, 2025 • Pasithea Therapeutics Corp. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May 6, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pasithea Therapeutics Corp., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, dated as of March 17, 2025, as amended, by and between the Company and H.C. Wainwright & Co., LLC.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Pasithea Therapeutics Corp.
Placement Agent Common Stock Purchase Warrant • May 1st, 2025 • Pasithea Therapeutics Corp. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the [Stockholder Approval Date]2 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [the date that is the five (5) year anniversary of the Stockholder Approval Date, provided that, if such date is not a Trading Day, the date that is the immediately following Trading Day]3 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Pasithea Therapeutics Corp., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is iss

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Silo Pharma, Inc.
Placement Agent Common Stock Purchase Warrant • April 25th, 2025 • Silo Pharma, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the [Shareholder Approval Date]1 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Silo Pharma, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, dated as of March 5, 2025, by and between the Company and H.C. Wainwright & Co., LLC, as amended.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT NANOVIBRONIX, INC.
Placement Agent Common Stock Purchase Warrant • April 22nd, 2025 • NanoVibronix, Inc. • Orthopedic, prosthetic & surgical appliances & supplies • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the date that is the __________ year anniversary following the Stockholder Approval Date, provided that, if such date is not a Trading Day, the date that is the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from NanoVibronix, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being iss

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Citius Pharmaceuticals, Inc.
Placement Agent Common Stock Purchase Warrant • April 2nd, 2025 • Citius Pharmaceuticals, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after October 2, 2025 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 1, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Citius Pharmaceuticals, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and H.C. Wainwright & Co., LLC, dated as of April 10, 2024, as amended.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT GRI BIO, INC.
Placement Agent Common Stock Purchase Warrant • April 2nd, 2025 • GRI Bio, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 1, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from GRI Bio, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock (as defined herein). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Engagement Agreement by and between the Company and H.C. Wainwright & Co., LLC, dated as of October 21, 2024, as amended on March 7, 2025.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Surf Air Mobility Inc.
Placement Agent Common Stock Purchase Warrant • April 1st, 2025 • Surf Air Mobility Inc. • Air transportation, nonscheduled

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 31, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Surf Air Mobility Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT GRI BIO, INC.
Placement Agent Common Stock Purchase Warrant • March 26th, 2025 • GRI Bio, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the [Stockholder Approval Date]2 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____________3 (the “Termination Date”) but not thereafter, to subscribe for and purchase from GRI Bio, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock (as defined herein). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Engagement Agreement by and between the Company and [ ], dated as of [ ].

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT SENESTECH, INC.
Placement Agent Common Stock Purchase Warrant • March 11th, 2025 • SenesTech, Inc. • Agricultural chemicals • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (as defined below) (the “Initial Exercise Date”), and on or prior to 5:00 p.m. (New York City time) on the date that is eighteen (18) months after the Stockholder Approval Date, provided that, if such date is not a Trading Day, the date that is the immediately following Trading Day (the “Termination Date”) but not thereafter, to subscribe for and purchase from SenesTech, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock (as defined herein). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). Thi

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT RESHAPE LIFE SCIENCES INC.
Placement Agent Common Stock Purchase Warrant • February 20th, 2025 • ReShape Lifesciences Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (as defined below) (the “Initial Exercise Date”) and on the later of (i) twelve (12) days after the Stockholder Approval Date and (ii) the earlier of (x) the closing date of the transactions contemplated by the Merger Agreement (as defined below) and (y) sixty (60) days after the Stockholder Approval Date, provided that, if such date is not a trading date is not a Trading Day, then the immediately preceding Trading Day and in no event later than February 14, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from ReShape Lifesciences Inc., a Delaware corporation (the “Company”), up to _____________ shares (as subject to adjustment hereunder, the “Wa

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT BIO-PATH HOLDINGS, INC.
Placement Agent Common Stock Purchase Warrant • February 12th, 2025 • Bio-Path Holdings, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the [Stockholder Approval Date]1 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on __________2(the “Termination Date”) but not thereafter, to subscribe for and purchase from Bio-Path Holdings, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Engagement Agreement by and between the Company and [ ].

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT SeaStar Medical Holding Corporation
Placement Agent Common Stock Purchase Warrant • February 3rd, 2025 • SeaStar Medical Holding Corp • Surgical & medical instruments & apparatus

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 3, 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from SeaStar Medical Holding Corporation, a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain engagement letter, dated as of May 17, 2024, by and between the Company and H.C. Wainwright & Co., LLC.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Enveric Biosciences, Inc.
Placement Agent Common Stock Purchase Warrant • January 30th, 2025 • Enveric Biosciences, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the [Stockholder Approval Date]1 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _______2 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Enveric Biosciences, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, dated as of December 8, 2024, by and between the Company and H.C. Wainwright & Co., LLC, as amended.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT GT Biopharma, Inc.
Placement Agent Common Stock Purchase Warrant • January 27th, 2025 • GT Biopharma, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [____________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [_____], 20301 (the “Termination Date”) but not thereafter, to subscribe for and purchase from GT Biopharma, Inc., a Delaware corporation (the “Company”), up to [______] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Placement Agency Agreement, by and between the Company and Roth Capital Partners, LLC, dated as of [____], 2025.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Carmell corporation
Placement Agent Common Stock Purchase Warrant • December 31st, 2024 • Carmell Corp • Surgical & medical instruments & apparatus • New York

HIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Brookline Capital Markets, a division of Arcadia Securities LLC or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after 5:00 p.m. (New York City time) on _______, 2025[1] (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ____________, 2030[2](the “Termination Date”) but not thereafter, to subscribe for and purchase from Carmell Corporation, a Delaware corporation (the “Company”), up to 556,195 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain engagement letter agreement, by and between the Company and the Holder, dated a

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Kartoon studios, inc.
Placement Agent Common Stock Purchase Warrant • December 18th, 2024 • Kartoon Studios, Inc. • Services-motion picture & video tape production • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ________or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date that Stockholder Approval (as defined below) is obtained and deemed effective and the NYSE American approves of the supplemental listing application related to such Stockholder Approval (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on December 18, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Kartoon Studios, Inc., a Nevada corporation (the “Company”), up to ________shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagem

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT HWH INTERNATIONAL inc.
Placement Agent Common Stock Purchase Warrant • December 10th, 2024 • HWH International Inc. • Wholesale-drugs, proprietaries & druggists' sundries • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from HWH International Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Placement Engagement Agreement, by and between the Company and D Boral Capital LLC, dated as of [____________], 2024.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT
Placement Agent Common Stock Purchase Warrant • November 7th, 2024 • Nuwellis, Inc. • Electromedical & electrotherapeutic apparatus • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after May [_], 20251 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on May [_], 20302 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Nuwellis, Inc., a Delaware corporation (the “Company”), up to [____] shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Investment Banking Agreement, dated as of August 20, 2024, as amended, (the “Investment Banking Agreement”), by and between the Company and Ladenburg Thalmann & Co. Inc.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT lomond therapeutics holdings, inc.
Placement Agent Common Stock Purchase Warrant • November 7th, 2024 • Lomond Therapeutics Holdings, Inc. • Blank checks

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on the fourth anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Lomond Therapeutics Holdings, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain engagement letter, dated as of February 12, 2024 by a

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT STRYVE FOODS, INC.
Placement Agent Common Stock Purchase Warrant • November 6th, 2024 • Stryve Foods, Inc. • Food and kindred products • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and until on or prior to 5:00 p.m. (New York City time) on ____1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Stryve Foods, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT Kartoon studios, inc.
Placement Agent Common Stock Purchase Warrant • October 18th, 2024 • Kartoon Studios, Inc. • Services-motion picture & video tape production • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Kartoon Studios, Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and Roth Capital Partners, LLC, dated as of September 4, 2024.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT RICHTECH ROBOTICS INC.
Placement Agent Common Stock Purchase Warrant • September 5th, 2024 • Richtech Robotics Inc. • General industrial machinery & equipment, nec • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on August 29, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Richtech Robotics Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and Rodman & Renshaw LLC, dated as of August 29, 2024.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT RICHTECH ROBOTICS INC.
Placement Agent Common Stock Purchase Warrant • August 27th, 2024 • Richtech Robotics Inc. • General industrial machinery & equipment, nec • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Richtech Robotics Inc., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock (as defined below). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and Rodman & Renshaw LLC, dated as of August [_], 2024.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT AIRSHIP AI HOLDINGS, INC.
Placement Agent Common Stock Purchase Warrant • August 22nd, 2024 • Airship AI Holdings, Inc. • Services-prepackaged software • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Airship AI Holdings, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT MOLECULIN BIOTECH, INC.
Placement Agent Common Stock Purchase Warrant • August 15th, 2024 • Moleculin Biotech, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the [Stockholder Approval Date] (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____(the “Termination Date”) but not thereafter, to subscribe for and purchase from Moleculin Biotech, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain engagement agreement by and between the Company and H.C. Wainwright & Co., LLC, dated as of June 8, 2024.

FORM OF PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT SYRA HEALTH CORP.
Placement Agent Common Stock Purchase Warrant • August 15th, 2024 • Syra Health Corp • Services-employment agencies • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Syra Health Corp., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, by and between the Company and Rodman & Renshaw LLC, dated as of July 3, 2024.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT ASSURE HOLDINGS CORP.
Placement Agent Common Stock Purchase Warrant • July 18th, 2024 • Assure Holdings Corp. • Surgical & medical instruments & apparatus • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the [the Shareholder Approval Date]1 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _____2 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Assure Holdings Corp., a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain Engagement Agreement, dated as of [ ], by and between the Company and [ ], as amended.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT INTERACTIVE STRENGTH INC.
Placement Agent Common Stock Purchase Warrant • June 27th, 2024 • Interactive Strength, Inc. • Electronic & other electrical equipment (no computer equip) • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after [_____________] (the “Initial Exercise Date”) and until on or prior to 5:00 p.m. (New York City time) on [____]____, [ (the “Termination Date”) but not thereafter, to subscribe for and purchase from Interactive Strength Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock (as defined herein). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is issued pursuant to that certain engagement letter, dated as of May 8, 2024, by and between the Company and H.C. Wainwright & Co., LLC.

PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT GRI BIO, INC.
Placement Agent Common Stock Purchase Warrant • June 27th, 2024 • GRI BIO, Inc. • Pharmaceutical preparations • New York

THIS PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Stockholder Approval Date (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on June 26, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from GRI Bio, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock (as defined herein). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant is being issued pursuant to that certain Engagement Agreement by and between the Company and H.C. Wainwright & Co., LLC, dated as of May 3, 2024.